首页> 外文OA文献 >Safety, tolerability and efficacy of indacaterol, a novel once-daily β-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

【2h】

Safety, tolerability and efficacy of indacaterol, a novel once-daily β-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

机译：新型每日一次β-激动剂茚达特罗在COPD患者中的安全性，耐受性和有效性：一项为期28天的随机，安慰剂对照临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Beier, Jutta; Chanez, Pascal; Martinot, J.-B. Jean-Benoit; Schreurs, A.J.M.; Tkáčová, R. Ružena; Bao, Weibin; Jack, Damon; Higgins, Mark;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial. [J] . Beier J, Chanez P, Martinot JB, Pulmonary pharmacology & therapeutics . 2007,第6期

机译：安全性，耐受性和新型每日一次β（2）激动剂茚达特罗在COPD患者中的作用：一项为期28天的随机，安慰剂对照临床试验。
2. Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study. [J] . Yang WH, Martinot JB, Pohunek P, Annals of allergy, asthma, and immunology . 2007,第6期

机译：新型每日一次的β2-激动剂茚达特罗在哮喘患者中的耐受性：一项随机，安慰剂对照，为期28天的安全性研究。
3. Bronchodilator efficacy of single doses of indacaterol in Japanese patients with COPD: A randomised, double-blind, placebo-controlled trial [J] . KatoM., MakitaH., UemuraK., Allergology international: official journal of the Japanese Society of Allergology . 2010,第3期

机译：单剂量茚达特罗在日本COPD患者中的支气管扩张剂疗效：一项随机，双盲，安慰剂对照试验
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. The Safety Tolerability and Efficacy of Once-Daily Memantine (28 mg): A Multinational Randomized Double-Blind Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors [O] . George T. Grossberg, Facundo Manes, Ricardo F. Allegri, -1

机译：每日一次美金刚胺（28 mg）的安全性耐受性和功效：针对中度至重度阿尔茨海默氏病患者服用胆碱酯酶抑制剂的多国性随机双盲安慰剂对照试验
7. Bronchodilator Efficacy of Single Doses of Indacaterol in Japanese Patients with COPD: A Randomised, Double-Blind, Placebo-Controlled Trial [O] . Motokazu Kato, Hironi Makita, Koji Uemura, 2010

机译：日本COpD患者单剂量茚达特罗的支气管扩张剂疗效：随机，双盲，安慰剂对照试验

Safety, tolerability and efficacy of indacaterol, a novel once-daily β-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

摘要

著录项

相似文献

相关主题

期刊订阅